Analysing demand and cost of toric IOLs in hospitals

Article

Study results help shed light on using toric IOLs on corneal astigmatism patients

"We were interested in understanding our patient demographic in greater detail so as to establish the need for toric lens provision. We could then plan its probable cost and implementation," said Dr Muhtaseb, previous consultant ophthalmologist at the Singleton Hospital Abertawe Bro Morgannwg University NHS Trust, Swansea, UK.

Compiling the study

At the time of cataract surgery a toric IOL (Rayner TFlex, UK) was implanted to correct for the corneal astigmatism. "We did not consider analysing wavefront errors or other data," added Dr Muhtaseb, "Our focus was on the main element of a patient's clinical picture that we could treat and that would greatly affect the quality of the surgical outcome."

There were minimal factors affecting the results. Dr Mohammed explained. "All patients were seen in the same department by one of the same four technicians, all using the same model of IOL Master, and all patients had surgery using the same model of phacoemulsification device (Storz Millennium)."

Beneficial to hospitals

The measured corneal astigmatism of the majority of the study group (79.5%) was 1.5 D or less. A little less than a quarter of the patients involved in the study had a corneal astigmatism of 0.5 D or less and only about 6.5% of the patients had a corneal astigmatism of more than 1.5 D. This data will prove useful to hospitals in determining the level of need for toric IOLs and how much it will cost to implement the use of these lenses in this setting.

"The data from this study shouldn't only be confined to NHS practices," according to Dr Muhtaseb. "These findings will also benefit patients being treated in private practice." He noted that further clinical data from a greater patient population and using a dedicated corneal topographer could offer a more clinically 'ideal' situation to this type of study, however, the IOLMaster was used as it is practical and relevant to a real-life scenario for many surgeons. In the future, Dr Muhtaseb would like to proceed with a further study of the clinical outcomes and patient satisfaction after toric IOL implantation.

"We hope, however, that our study has added weight to the currently available literature that supports the use of toric IOLs through demonstrating the need for them," concluded Dr Muhtaseb.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
© 2025 MJH Life Sciences

All rights reserved.